Visiting Nurse Assn Of Southeast Missouri, Inc | |
Po Box 768, Kennett, Missouri 63857 | |
(573) 888-5892 | |
Name | Visiting Nurse Assn Of Southeast Missouri, Inc |
---|---|
Location | Po Box 768, Kennett, Missouri |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 267050 |
Ownership Type | Voluntary Non-profit - Private |
Service Area Zip Codes | 63701, 63702, 63703, 63730, 63735, 63736, 63740, 63742, 63744, 63745, 63750, 63751, 63755, 63760, 63763, 63764, 63766, 63767, 63769, 63771, 63774, 63780, 63782, 63784, 63785, 63787, 63801, 63820, 63821, 63822, 63823, 63825, 63826, 63827, 63829, 63830, 63833, 63834, 63837, 63839, 63840, 63841, 63845, 63846, 63847, 63848, 63849, 63851, 63852, 63853, 63855, 63857, 63860, 63862, 63863, 63866, 63867, 63868, 63869, 63870, 63873, 63874, 63876, 63877, 63879, 63880, 63882, 63901, 63932, 63933, 63934, 63935, 63936, 63937, 63939, 63940, 63943, 63944, 63945, 63951, 63952, 63953, 63954, 63956, 63957, 63960, 63961, 63964, 63965, 63966, 63967 |
NPI Number | 1205828183 |
Organization Name | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Doing Business As | VNA OF SOUTHEAST MISSOURI |
Address | 1124 Independence Ave, Kennett, MO 63857 |
Phone Number | 573-888-5892 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
NPI Number | 1326190596 |
Organization Name | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Doing Business As | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Address | 1124 Independence Ave, Kennett, MO 63857 |
Phone Number | 573-888-5892 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
NPI Number | 1427102292 |
Organization Name | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Doing Business As | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Address | 1124 Independence Ave, Kennett, MO 63857 |
Phone Number | 573-888-5892 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
NPI Number | 1447507983 |
Organization Name | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Doing Business As | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Address | 1124 Independence Ave, Kennett, MO 63857 |
Phone Number | 573-888-5892 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
NPI Number | 1710959309 |
Organization Name | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Address | 1124 Independence Ave, Kennett, MO 63857 |
Phone Number | 573-888-5892 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
NPI Number | 1801868492 |
Organization Name | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Doing Business As | VISITING NURSE ASSOCIATION OF SOUTHEAST MISSOURI INC |
Address | 1124 Independence Ave, Kennett, MO 63857 |
Phone Number | 573-888-5892 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
Quality Rating: |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 98.3 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.8 | 99.6 |
How often the home health team checked patients for depression | 99.6 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 67.9 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 71.3 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.4 | 96.4 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 79.2 | 79.6 |
How often patients got better at getting in and out of bed | 83.7 | 81.1 |
How often patients got better at bathing | 84.2 | 82.3 |
How often patients’ breathing improved | 84.6 | 82.8 |
How often patients’ wounds improved or healed after an operation | 95.3 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 74.1 | 75 |
How often home health patients had to be admitted to the hospital | 13.2 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.6 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 86.1 | 94 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
The patient survey data of Visiting Nurse Assn Of Southeast Missouri, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 92 | 88 |
Percent of patients who reported that their home health team communicated well with them | 89 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 80 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 89 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 85 | 78 |
News Archive
"Genetically modified mosquitoes could prove effective in tackling dengue fever and other insect-borne diseases," according to the results of a study by a U.K.-based scientific team published in the journal Nature Biotechnology on Sunday, BBC News reports.
Fainting has a strong genetic predisposition, according to new research published in the August 7, 2012, print issue of Neurology, the medical journal of the American Academy of Neurology. Fainting, also called vasovagal syncope, is a brief loss of consciousness when your body reacts to certain triggers, such as emotional distress or the sight of blood.
According to the Ministry of Health in China at least 7 deaths have now been linked to the injectable antibiotic clindamycin phosphate glucose.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
› Verified 3 days ago
Visiting Nurse Assn Of Southeast Missouri, Inc Location: Po Box 768, Kennett, Missouri 63857 Ratings: Phone: (573) 888-5892 |